ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Deciphera expands cancer trial after seeing early data fiercebiotech
January 04, 2019Deciphera Pharmaceuticals has?posted?data from a phase 1 trial of its small molecule switch control inhibitor of CSF1R, DCC-3014. The early-phase data have emboldened Deciphera to expand the trial to include patients with....
Pharma Sources Insight January 2025
